Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

Nuclear Factor kappa B (NFκB) is a eukaryotic transcription factor that is constitutively active in human cancers and can be inhibited by the naturally occurring sesquiterpene lactone, parthenolide (P).

[1]  J. Jester,et al.  A role for NF-κB–dependent gene transactivation in sunburn , 2000 .

[2]  J. Kral,et al.  The NF-κB/IκB signaling system: A molecular target in breast cancer therapy , 2005 .

[3]  O. Melnyk,et al.  Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. , 1999, The Journal of urology.

[4]  R. Coleman,et al.  Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  John Calvin Reed,et al.  TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Liang Cheng,et al.  Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate , 2004, Clinical Cancer Research.

[7]  E. Schwarz,et al.  Increased radiation‐induced apoptosis of Saos2 cells via inhibition of NFκB: A role for c‐Jun N‐terminal kinase , 2005, Journal of Cellular Biochemistry.

[8]  T. Libermann,et al.  Life and Death in Cancer GADD45 α and γ are Critical Regulators of NF- κB Mediated Escape from Programmed Cell Death , 2005 .

[9]  G. Sledge,et al.  Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide , 2000, Oncogene.

[10]  S. Yeh,et al.  Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. , 2003, Cancer research.

[11]  C. Smith,et al.  A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. , 2001, Immunity.

[12]  C. Bucana,et al.  Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. , 2000, Cancer research.

[13]  F. Zazzeroni,et al.  JNK: a killer on a transcriptional leash , 2003, Cell Death and Differentiation.

[14]  M. Schmitz,et al.  Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF‐κB , 1997, FEBS letters.

[15]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[16]  C. Bucana,et al.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. , 1997, The American journal of pathology.

[17]  Yahong Lin,et al.  A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis , 2003, Cell.

[18]  L. Young,et al.  Expression of the tumour necrosis factor receptor‐associated factors 1 and 2 in Hodgkin's disease , 2001, The Journal of pathology.

[19]  G. Sledge,et al.  Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.

[20]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[21]  I. Merfort,et al.  Role of cysteine residues of p65/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential. , 2004, Life sciences.

[22]  I. Herr,et al.  JNK/SAPK activity contributes to TRAIL-induced apoptosis , 1999, Cell Death and Differentiation.

[23]  Derick R. Peterson,et al.  The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. , 2005, Blood.

[24]  T. Shono,et al.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.

[25]  G. Stark,et al.  Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer , 2004, Oncogene.

[26]  P. Hylands,et al.  Efficacy of feverfew as prophylactic treatment of migraine. , 1985 .

[27]  S. Merajver,et al.  Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade. , 2003, Molecular cancer research : MCR.

[28]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[29]  Kwiyeom Yoon,et al.  TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors. , 2003, Biochemical and biophysical research communications.

[30]  G. Stark,et al.  NFκB-dependent signaling pathways , 2002 .

[31]  H. Nakshatri,et al.  Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-κB pathway in pancreatic carcinoma cells , 2005, Molecular Cancer Therapeutics.

[32]  Harikrishna Nakshatri,et al.  Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase , 2004, Oncogene.

[33]  G. Sledge,et al.  The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors. , 2001, Cancer research.

[34]  L. Dwoskin,et al.  Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2'-(14)C]nicotine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[35]  M. Ittmann,et al.  Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  C. Bucana,et al.  Nuclear Factor-κB Activity Correlates with Growth, Angiogenesis, and Metastasis of Human Melanoma Cells in Nude Mice , 2000 .

[37]  Francesca Zazzeroni,et al.  Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling , 2001, Nature.

[38]  C. Bocca,et al.  Microtubule-interfering activity of parthenolide. , 2004, Chemico-biological interactions.

[39]  Douglas B. Evans,et al.  Function of Nuclear Factor κB in Pancreatic Cancer Metastasis , 2003 .

[40]  A. Lin.  Activation of the JNK signaling pathway: Breaking the brake on apoptosis , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[41]  H. Nakshatri,et al.  NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1α , 1998 .

[42]  Masakazu Toi,et al.  Nuclear factor-κB inhibitors as sensitizers to anticancer drugs , 2005, Nature Reviews Cancer.

[43]  C. Dinney,et al.  Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  Choon Nam Ong,et al.  Suppressed NF-κB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-α-induced apoptosis in human cancer cells , 2004 .

[45]  S. Badve,et al.  The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer , 2005, Molecular Cancer Therapeutics.

[46]  H. Nakshatri,et al.  Repression of GADD153/CHOP by NF-κB: a possible cellular defense against endoplasmic reticulum stress-induced cell death , 2001, Oncogene.

[47]  C. Bucana,et al.  Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. , 1998, Cancer research.

[48]  G. Dong,et al.  IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas , 2001 .

[49]  Jing Wen,et al.  Oxidative Stress-mediated Apoptosis , 2002, The Journal of Biological Chemistry.

[50]  F. Meyskens,et al.  RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B. , 2001, Pigment cell research.

[51]  L. Dwoskin,et al.  Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2'-(14)C]nicotine. , 2001, Drug metabolism and disposition: the biological fate of chemicals.